EUVIMEDEUVIMED entdecken
Open Access

Platelet Mass Signatures and Thrombin-Activatable Fibrinolysis Inhibitor as Discriminators of Primary Thrombocytosis: Development of a Screening Algorithm in an Eastern Sudanese Cohort

Bashir A Bashir

Cureus · 31.03.2026

DOI: 10.7759/cureus.106174 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cureus, erschienen am 31.03.2026. Verfasst von Bashir A Bashir. Beteiligte Einrichtung: Department of Hematology, Faculty of Medical Laboratory Sciences, Port Sudan Ahlia University, Port Sudan, SDN. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

diagnostic modelplatelet indicesplateletcritroc curvetafithrombocytosis

Autor:innen und Institutionen

  • Department of Hematology, Faculty of Medical Laboratory Sciences, Port Sudan Ahlia University, Port Sudan, SDN.

Zitieren

APA

Bashir, B. A. (2026). Platelet Mass Signatures and Thrombin-Activatable Fibrinolysis Inhibitor as Discriminators of Primary Thrombocytosis: Development of a Screening Algorithm in an Eastern Sudanese Cohort. Cureus. https://doi.org/10.7759/cureus.106174

Vancouver

Bashir BA. Platelet Mass Signatures and Thrombin-Activatable Fibrinolysis Inhibitor as Discriminators of Primary Thrombocytosis: Development of a Screening Algorithm in an Eastern Sudanese Cohort. Cureus. 2026. doi:10.7759/cureus.106174

BibTeX
@article{Bashir2026,
  author = {Bashir, Bashir A},
  title = {Platelet Mass Signatures and Thrombin-Activatable Fibrinolysis Inhibitor as Discriminators of Primary Thrombocytosis: Development of a Screening Algorithm in an Eastern Sudanese Cohort},
  journal = {Cureus},
  year = {2026},
  doi = {10.7759/cureus.106174}
}
Kostenlos starten →